Quarterly report pursuant to Section 13 or 15(d)

Significant Operating and Nonoperating Items (Details)

v3.5.0.2
Significant Operating and Nonoperating Items (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2016
Oct. 02, 2015
Sep. 30, 2016
Oct. 02, 2015
Other Operating Charges        
Other operating charges $ 222 $ 264 $ 830 $ 1,166
Impairment of Intangible Assets (Excluding Goodwill) 0 41 0 473
Venezuelan Trademark impairment   3    
Costs incurred to refranchise NA territories 73   170  
Charges associated with pending and closed transactions 1,204 859 561  
Noncapitalizable transaction costs     37  
Other Nonoperating Items        
Gains (Losses) on Extinguishment of Debt       (320)
Equity Income (Loss) - Net        
Our proportionate share of unusual or infrequent items charge/(gain) recorded by equity method investees 14 (3) 35 79
Other Income (Loss) - Net        
Benefit (charge) due to refranchising of territories or deconsolidation of bottlers   (815) 1,323 (848)
Remeasurement on previously held equity interest 0 0 0 19
Valuation of shares in equity method investee gains/ (loss) 0 0 0 (6)
Foreign currency exchange gain on Euro denominated debt       277
Latin America [Member]        
Other Operating Charges        
Productivity, integration and restructuring initiatives   4   7
Corporate        
Other Operating Charges        
Productivity, integration and restructuring initiatives 14 29 42 53
Impairment of Intangible Assets (Excluding Goodwill)   48   418
Cash Contribution Expense     100 100
Noncapitalizable transaction costs     29  
Other Nonoperating Items        
Gains (Losses) on Extinguishment of Debt       (320)
Equity Income (Loss) - Net        
Our proportionate share of unusual or infrequent items charge/(gain) recorded by equity method investees     3  
Other Income (Loss) - Net        
Benefit (charge) due to refranchising of territories or deconsolidation of bottlers   (21) 1,323 (21)
Net Gains From Investee Transactions, Equity Investment Sales and other gains   1,402 18 1,402
Remeasurement on previously held equity interest       19
Valuation of shares in equity method investee gains/ (loss)       (6)
Bottling investments [Member]        
Other Operating Charges        
Productivity, integration and restructuring initiatives 22 151 300 361
Costs incurred to refranchise NA territories 73   170  
Noncapitalizable transaction costs     8  
Equity Income (Loss) - Net        
Our proportionate share of unusual or infrequent items charge/(gain) recorded by equity method investees 14   32 76
Other Income (Loss) - Net        
Benefit (charge) due to refranchising of territories or deconsolidation of bottlers (1,089) (794) (1,657) (827)
North America [Member]        
Other Operating Charges        
Productivity, integration and restructuring initiatives 22 31 80 104
Other Income (Loss) - Net        
Cost incurred to convert bottling agreement 17   17  
Productivity and Reinvestment [Member]        
Other Operating Charges        
Productivity, integration and restructuring initiatives 59 141 187 323
Integration of German Bottling and Distribution Operation [Member]        
Other Operating Charges        
Productivity, integration and restructuring initiatives   75 240 204
Venezuelan subsidiary        
Other Operating Charges        
Venezuelan Trademark impairment   3   55
Accounts Receivable Write-Down 76   76 56
Other Income (Loss) - Net        
Remeasurement Charges on Subsidiary Assets       27
Venezuelan subsidiary | Latin America [Member]        
Other Operating Charges        
Accounts Receivable Write-Down 76   76  
Venezuelan subsidiary | Corporate        
Other Operating Charges        
Accounts Receivable Write-Down       111
Other Income (Loss) - Net        
Remeasurement Charges on Subsidiary Assets       27
South African bottling operations [Member] | Corporate        
Other Income (Loss) - Net        
Deconsolidation, Gain (Loss), Amount $ (21)   $ (21)  
Trademarks [Member]        
Other Operating Charges        
Impairment of Intangible Assets (Excluding Goodwill)   $ 38   $ 418